Trending Topics in Gastroenterology
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
Explore current gastroenterology questions, clinical answers, and emerging research by topic.
KRASG12D mutation plays a pivotal role in pancreatic tumorigenesis, particularly in the context of the adult pancreas, which is characterized by unique biological features and challenges. Below is...
High fecal immunochemical test (FIT) results in colorectal cancer (CRC) patients are strongly associated with significantly worse 1-year mortality outcomes, according to the study. Below is a detailed...
The combination of encorafenib, cetuximab, and mFOLFOX6 has been studied as a first-line treatment for patients with BRAF V600E–mutated metastatic colorectal cancer (mCRC), a particularly aggressive cancer subtype...
The international, randomized phase 3 clinical trial compared trastuzumab deruxtecan with ramucirumab plus paclitaxel as second-line treatment options for patients with HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma...
The new perioperative strategy in gastric cancer involves incorporating immunotherapy into the existing chemotherapy regimen to improve outcomes for patients with resectable gastric and gastroesophageal junction cancers. These...
The rising use of CT (computed tomography) scans has sparked concerns about its potential long-term impact on cancer risk, as highlighted by a recent modeling study. Below is...
The four key genes linked to worse gastric cancer outcomes, as identified by new research from Brazil, are BRCA2, CDH1, RHOA, and TP53. Here’s a detailed breakdown of...
Catching gastric cancer early is critically important for improving survival outcomes, especially given the poor prognosis associated with late-stage diagnosis. Early detection involves a structured, multidisciplinary approach that...
The ATOMIC trial evaluated the efficacy of combining the PD-L1 inhibitor atezolizumab with standard adjuvant chemotherapy (FOLFOX) in patients with stage III colon cancer that is mismatch repair-deficient...
The use of oxaliplatin in chemotherapy for colorectal cancer (CRC) varies in effectiveness depending on the stage of the disease and the age of the patient. Here's a...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.